Dizal (Jiangsu) Pharmaceutical Co. Ltd.SSE: 688192

Announcement on Expected Loss in Performance for 2025

Jan 13, 2026 · Issued by Dizal (Jiangsu) Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 13, 2026

On 6ix: 6ix.com/news/announcement-on-expected-loss-in-performance-for-2025-160

Announcement on Expected Loss in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix

Earlier from Dizal (Jiangsu) Pharmaceutical

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jan 10
Announcement on Resolutions of the 18th Meeting of the 2nd Board of DirectorsDec 25, 2025
Announcement on the Resignation of Independent DirectorsDec 19, 2025
Announcement on Changing Registered Capital, Amending the Articles of Association, and Handling Industrial and Commercial Change RegistrationDec 18, 2025
Announcement on Listing and Circulation of Shares from the 1st Exercise Window of the 2nd Exercise Period under the 2020 Employee Stock Option PlanDec 16, 2025

Later from Dizal (Jiangsu) Pharmaceutical

Announcement on the Results of the First Partial Vesting of the 3rd Vesting Period for the First Category of Incentive Objects under the 2022 Restricted Stock Incentive Plan, Partial Vesting of the 2nd Vesting Period for the Second Category of Incentive Recipients under the Initial Grant, Partial Vesting of the 1st Vesting Period for the Reserved Grant Objects, and Stock ListingJan 15
Announcement on Changing English Name of the Company, Amending the "Articles of Association", and Handling Industrial and Commercial Change RegistrationJan 22
Announcement on the Results of the Partial Vesting of the 2nd Vesting Period for the Second Category of Incentive Recipients under the Initial Grant, Partial Vesting of the 1st Vesting Period for the Reserved Grant Objects under the 2022 Restricted Stock Incentive Plan, and Stock ListingJan 29
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Early Return of Idle Raised Funds for Temporary Supplementary Working CapitalMar 7

All Dizal (Jiangsu) Pharmaceutical news releases

Follow Dizal (Jiangsu) Pharmaceutical into a list and get an email when it puts out news.

Follow Dizal (Jiangsu) Pharmaceutical